Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Ragosa Mark exercised options for 9,104 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Ragosa Mark (CHIEF FINANCIAL OFFICER) exercised options for 9,104 Kiniksa Pharmaceuticals International, Plc shares, leaving 20,854 shares. Filed Sep 3, 2026 (Form 4).
- Options exercised
- 9,104 shares
- Holding after
- 20,854 shares
- Trading plan
- No
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 2,694 | 18,848 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 1,750 | 20,598 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 1,591 | 22,189 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Option exercise | 3,069 | 25,258 | Direct | |
| Sep 1, 2026 | Class A Ordinary Share | Shares withheld for tax | 4,404 | US$79.28 | 20,854 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Ragosa Mark
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Ragosa Mark · Apr 8, 2026
- Form 4 · Ragosa Mark · Apr 3, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026